Literature DB >> 16962066

A randomized controlled trial of the effect of D-cycloserine on extinction and fear conditioning in humans.

Adam J Guastella1, Peter F Lovibond, Mark R Dadds, Philip Mitchell, Rick Richardson.   

Abstract

Previous research has shown that D-cycloserine (DCS) facilitates extinction of Pavlovian fear conditioning in rats and enhances exposure therapy in humans. The aim of this study was to test the effect of DCS on extinction of fear conditioning in humans. In three experiments, 238 participants were given either DCS (50 or 500 mg) or placebo 2-3 h before extinction training following a differential shock conditioning paradigm. Clear extinction and recovery (return of fear) effects were observed on both skin conductance and self-reported shock expectancy measures in three studies. DCS had no influence on these effects. The same pattern was observed when the analysis was restricted to aware participants or to good conditioners, when fear-relevant cues (pictures of snakes) were used as the conditioned stimuli, or when analysis was restricted to heightened snake-fearful participants. These results suggest that DCS may not enhance the extinction, or prevent the recovery, of learned fear in a differential Pavlovian conditioning paradigm in humans. Further experimental research is needed to better understand the mechanisms underlying the therapeutic effects of DCS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962066     DOI: 10.1016/j.brat.2006.07.005

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  49 in total

Review 1.  Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.

Authors:  Michael W Otto; M Alexandra Kredlow; Jasper A J Smits; Stefan G Hofmann; David F Tolin; Rianne A de Kleine; Agnes van Minnen; A Eden Evins; Mark H Pollack
Journal:  Biol Psychiatry       Date:  2015-09-25       Impact factor: 13.382

Review 2.  Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine.

Authors:  Stefan G Hofmann; Mark H Pollack; Michael W Otto
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

Review 3.  Neural mechanisms of extinction learning and retrieval.

Authors:  Gregory J Quirk; Devin Mueller
Journal:  Neuropsychopharmacology       Date:  2007-09-19       Impact factor: 7.853

4.  D-cycloserine facilitates context-specific fear extinction learning.

Authors:  Mark E Bouton; Drina Vurbic; Amanda M Woods
Journal:  Neurobiol Learn Mem       Date:  2008-08-15       Impact factor: 2.877

5.  Randomized controlled trial of d-cycloserine in cocaine dependence: Effects on contingency management and cue-induced cocaine craving in a naturalistic setting.

Authors:  Matthew W Johnson; Natalie R Bruner; Patrick S Johnson; Kenneth Silverman; Meredith S Berry
Journal:  Exp Clin Psychopharmacol       Date:  2019-08-01       Impact factor: 3.157

Review 6.  Pharmacological treatment of PTSD - established and new approaches.

Authors:  Thomas Steckler; Victoria Risbrough
Journal:  Neuropharmacology       Date:  2011-06-29       Impact factor: 5.250

7.  Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans.

Authors:  Christine A Rabinak; Mike Angstadt; Maryssa Lyons; Shoko Mori; Mohammed R Milad; Israel Liberzon; K Luan Phan
Journal:  Neurobiol Learn Mem       Date:  2013-09-19       Impact factor: 2.877

8.  Augmentation of exposure therapy with post-session administration of D-cycloserine.

Authors:  Candyce D Tart; Pamela R Handelsman; Lindsey B Deboer; David Rosenfield; Mark H Pollack; Stefan G Hofmann; Mark B Powers; Michael W Otto; Jasper A J Smits
Journal:  J Psychiatr Res       Date:  2012-10-23       Impact factor: 4.791

Review 9.  Post-traumatic stress disorder: emerging concepts of pharmacotherapy.

Authors:  Dewleen G Baker; Caroline M Nievergelt; Victoria B Risbrough
Journal:  Expert Opin Emerg Drugs       Date:  2009-06       Impact factor: 4.191

10.  A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans.

Authors:  Barbara Olasov Rothbaum; Matthew Price; Tanja Jovanovic; Seth D Norrholm; Maryrose Gerardi; Boadie Dunlop; Michael Davis; Bekh Bradley; Erica J Duncan; Albert Rizzo; Kerry J Ressler
Journal:  Am J Psychiatry       Date:  2014-06       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.